vs
Side-by-side financial comparison of PROTHENA CORP PUBLIC LTD CO (PRTA) and Youxin Technology Ltd (YAAS). Click either name above to swap in a different company.
Youxin Technology Ltd is the larger business by last-quarter revenue ($39.4K vs $21.0K, roughly 1.9× PROTHENA CORP PUBLIC LTD CO).
Prothena Corporation plc is a late-stage clinical biotechnology firm focused on developing and commercializing innovative antibody therapies for neurodegenerative disorders, rare diseases and immune-related conditions. Its core pipeline targets unmet medical needs including amyloidosis, Parkinson's and Alzheimer's, serving key markets across North America, Europe and the Asia-Pacific.
Youxin Technology Ltd is a China-based automotive digital service provider. It operates used car trading platforms, offers new car sales support, auto financing referrals, and after-sales resource matching for consumers and auto industry participants across mainland China, focusing on optimizing vehicle transaction efficiency.
PRTA vs YAAS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.0K | $39.4K |
| Net Profit | — | $-127.9K |
| Gross Margin | — | 67.9% |
| Operating Margin | — | — |
| Net Margin | — | -324.8% |
| Revenue YoY | -99.0% | — |
| Net Profit YoY | 62.7% | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.0K | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $4.4M | $39.4K | ||
| Q1 25 | $2.8M | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $970.0K | — | ||
| Q2 24 | $132.0M | — | ||
| Q1 24 | $50.0K | — |
| Q4 25 | — | — | ||
| Q3 25 | $-36.5M | — | ||
| Q2 25 | $-125.8M | $-127.9K | ||
| Q1 25 | $-60.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-59.0M | — | ||
| Q2 24 | $66.9M | — | ||
| Q1 24 | $-72.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 67.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | -1666.3% | — | ||
| Q2 25 | -1914.4% | — | ||
| Q1 25 | -2319.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -6857.0% | — | ||
| Q2 24 | 44.2% | — | ||
| Q1 24 | -163056.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | -1513.1% | — | ||
| Q2 25 | -2845.4% | -324.8% | ||
| Q1 25 | -2128.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -6082.6% | — | ||
| Q2 24 | 50.7% | — | ||
| Q1 24 | -144478.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | $-0.68 | — | ||
| Q2 25 | $-2.34 | — | ||
| Q1 25 | $-1.12 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.10 | — | ||
| Q2 24 | $1.22 | — | ||
| Q1 24 | $-1.34 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $307.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $280.5M | $-374.6K |
| Total Assets | $326.8M | $132.2K |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $307.5M | — | ||
| Q3 25 | $330.8M | — | ||
| Q2 25 | $371.4M | — | ||
| Q1 25 | $417.9M | — | ||
| Q4 24 | $471.4M | — | ||
| Q3 24 | $519.3M | — | ||
| Q2 24 | $564.1M | — | ||
| Q1 24 | $546.5M | — |
| Q4 25 | $280.5M | — | ||
| Q3 25 | $295.0M | — | ||
| Q2 25 | $324.3M | $-374.6K | ||
| Q1 25 | $437.7M | — | ||
| Q4 24 | $486.9M | — | ||
| Q3 24 | $534.4M | — | ||
| Q2 24 | $581.9M | — | ||
| Q1 24 | $502.4M | — |
| Q4 25 | $326.8M | — | ||
| Q3 25 | $352.6M | — | ||
| Q2 25 | $399.1M | $132.2K | ||
| Q1 25 | $495.3M | — | ||
| Q4 24 | $547.1M | — | ||
| Q3 24 | $595.3M | — | ||
| Q2 24 | $645.6M | — | ||
| Q1 24 | $623.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-163.6M | $-88.6K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-163.6M | — | ||
| Q3 25 | $-40.6M | — | ||
| Q2 25 | $-46.3M | $-88.6K | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $-150.1M | — | ||
| Q3 24 | $-45.2M | — | ||
| Q2 24 | $16.0M | — | ||
| Q1 24 | $-73.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
